Long-term Follow-up 15 Years After Duodenal Switch or Gastric Bypass for Super Obesity: a Randomized Controlled Trial
2023 (English)In: Obesity Surgery, ISSN 0960-8923, E-ISSN 1708-0428, Vol. 33, no 10, p. 2981-2990Article in journal (Refereed) Published
Abstract [en]
Background
In super obesity, Roux-en-Y gastric bypass (RYGB) may be insufficient why some surgeons advocate biliopancreatic diversion with duodenal switch (BPD/DS), a more malabsorptive procedure. There is a paucity of evidence regarding results beyond 10 years, especially after BPD/DS. The aim of this randomized controlled trial was to compare the long-term outcome of BPD/DS, and RYGB in patients with super obesity, i.e., body mass index (BMI) > 50 kg/m2.
Methods
This is a 13- to 17-year follow-up study of a single-center, single-blinded randomized trial in which 47 patients (BMI > 48 and eligible for bariatric surgery) were randomized 1:1 to BPD/DS and RYGB (25 men, 24 BPD/DS, 39.1 ± 9.9 years, BMI 54.5 ± 6.1 kg/m2). The primary outcome was weight loss. The study was financed by Swedish governmental funding of clinical research (ALF). Trial registration number: ISRCTN10940791.
Results
Thirty-four (18 BPD/DS) of the living 42 patients (81.0%) participated. BPD/DS resulted in higher BMI loss (20.4 ± 7.9 vs. 12.4 ± 8.6, p = .008) and higher percent of total body weight loss (37.5% ± 12.2 vs. 22.8% ± 14.8, p = .004). BPD/DS was associated with lower fasting glucose, glycated hemoglobin (HbA1c), and low-density lipoprotein (LDL) as well as lower hemoglobin. Adverse events were more common after BPD/DS (2.7 vs. 0.9 per patient, p = .004). The global assessment tool BAROS (Bariatric Analysis and Reporting Outcome System) demonstrated superior scores for BPD/DS (p = .047).
Conclusion
When compared to RYGB, BPD/DS results in superior weight loss and metabolic control as well as superior BAROS score, however, at the cost of more adverse events.
Place, publisher, year, edition, pages
Springer, 2023. Vol. 33, no 10, p. 2981-2990
Keywords [en]
Roux-en-Y gastric bypass, Biliopancreatic diversion with duodenal switch, Long-term results, Obesity, Weight loss, Diabetes mellitus, BAROS, Bariatric surgery
National Category
Surgery
Identifiers
URN: urn:nbn:se:uu:diva-517297DOI: 10.1007/s11695-023-06767-0ISI: 001049781200004PubMedID: 37584851OAI: oai:DiVA.org:uu-517297DiVA, id: diva2:1817494
Funder
Uppsala University2023-12-062023-12-062023-12-06Bibliographically approved